Study withdrawn without starting or enrolling subjects due to a business decision to not proceed with the project.

This study will evaluate the safety and efficacy of a new allergy medication

Study withdrawn prior to determining study details

Inclusion Criteria:

• Be at least 6 years of age, of any race, or either gender.
• Have a positive allergic history of ocular allergies and a positive skin test reaction to cat hair/dander, ragweed, tree and/or grass pollen within the past 24 months.
• Have a calculated best-corrected visual acuity of 0.6 logMar or better in each eye as measured using an ETDRS chart.
• Positive bilateral CAC reaction at Visit 1 & 2.

Exclusion Criteria:

• Have any known contraindications, allergies, or sensitivities to the use of any of the study medications, or their components.
• Any ocular condition that, in the opinion of the investigator, could affect the subject's safety or trial parameters
• Manifest signs or symptoms of clinically active allergic conjunctivitis in either eye at the baseline slit-lamp exam of any visit